Chemoinformaics analysis of 3-METHOXY-2,5-DIMETHYLPYRAZINE
| Molecular Weight | 138.17 | nRot | 1 |
| Heavy Atom Molecular Weight | 128.09 | nRig | 6 |
| Exact Molecular Weight | 138.079 | nRing | 1 |
| Solubility: LogS | -0.603 | nHRing | 1 |
| Solubility: LogP | 1.542 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.3599 |
| nHD | 0 | BPOL | 14.0481 |
| QED | 0.583 |
| Synth | 2.348 |
| Natural Product Likeliness | -1.292 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.554 |
| MDCK | 0.0000334 |
| BBB | 0.949 |
| PPB | 0.661968 |
| VDSS | 1.145 |
| FU | 0.286442 |
| CYP1A2-inh | 0.712 |
| CYP1A2-sub | 0.866 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.86 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.408 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.856 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.466 |
| CL | 9.971 |
| T12 | 0.493 |
| hERG | 0.02 |
| Ames | 0.037 |
| ROA | 0.308 |
| SkinSen | 0.655 |
| Carcinogencity | 0.443 |
| EI | 0.971 |
| Respiratory | 0.487 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.901072 |